1. Home
  2. WEAV vs KROS Comparison

WEAV vs KROS Comparison

Compare WEAV & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEAV
  • KROS
  • Stock Information
  • Founded
  • WEAV 2011
  • KROS 2015
  • Country
  • WEAV United States
  • KROS United States
  • Employees
  • WEAV N/A
  • KROS N/A
  • Industry
  • WEAV EDP Services
  • KROS Biotechnology: Pharmaceutical Preparations
  • Sector
  • WEAV Technology
  • KROS Health Care
  • Exchange
  • WEAV Nasdaq
  • KROS Nasdaq
  • Market Cap
  • WEAV 571.3M
  • KROS 565.0M
  • IPO Year
  • WEAV 2021
  • KROS 2020
  • Fundamental
  • Price
  • WEAV $7.75
  • KROS $15.55
  • Analyst Decision
  • WEAV Strong Buy
  • KROS Buy
  • Analyst Count
  • WEAV 5
  • KROS 14
  • Target Price
  • WEAV $15.10
  • KROS $20.56
  • AVG Volume (30 Days)
  • WEAV 851.2K
  • KROS 417.3K
  • Earning Date
  • WEAV 10-29-2025
  • KROS 11-05-2025
  • Dividend Yield
  • WEAV N/A
  • KROS N/A
  • EPS Growth
  • WEAV N/A
  • KROS N/A
  • EPS
  • WEAV N/A
  • KROS 0.47
  • Revenue
  • WEAV $220,834,000.00
  • KROS $232,844,000.00
  • Revenue This Year
  • WEAV $18.93
  • KROS $5,579.44
  • Revenue Next Year
  • WEAV $15.86
  • KROS N/A
  • P/E Ratio
  • WEAV N/A
  • KROS $33.52
  • Revenue Growth
  • WEAV 18.10
  • KROS 85820.30
  • 52 Week Low
  • WEAV $6.75
  • KROS $9.12
  • 52 Week High
  • WEAV $17.63
  • KROS $72.37
  • Technical
  • Relative Strength Index (RSI)
  • WEAV 50.22
  • KROS 57.26
  • Support Level
  • WEAV $7.58
  • KROS $15.23
  • Resistance Level
  • WEAV $8.00
  • KROS $15.85
  • Average True Range (ATR)
  • WEAV 0.24
  • KROS 0.48
  • MACD
  • WEAV 0.02
  • KROS -0.01
  • Stochastic Oscillator
  • WEAV 58.33
  • KROS 65.55

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue from subscription services.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: